November 12, 2013
CARLSBAD, Calif. and UTRECHT, The Netherlands –– One of the most comprehensive studies of genetic mutations in ovarian cancer was published today, demonstrating an unprecedented level of genetic variation that exists in both primary tumors and metastatic lesions of ovarian cancer. The study highlights potential new pathways for therapeutic intervention and suggests that sampling and [...]
Now Available from Salimetrics: SalivaBio High Quality Cryostorage Boxes
November 12, 2013
State College, PA -- Salivary bioscience is emerging as a scientific field which is centered in the space between multiple disciplines. The number of analytes that can be measured in saliva is increasing rapidly. As measurement capabilities advance, more information can be gained from samples that are archived. Archiving saliva samples using the right tools [...]
Cincinnati Children’s Joins Boston Children’s to Establish the Claritas Pediatric Genomic Network
November 12, 2013
Pediatric hospitals to share data and genomic testing infrastructure for the benefit of patients Cambridge, Nov 12— Cincinnati Children’s Medical Center has partnered with Claritas Genomics, a company formed by Boston Children’s Hospital and Life Technologies Corporation (NASDAQ: LIFE), to provide genomics-based diagnostics for pediatric patients. Cincinnati Children’s will work with Claritas and Boston Children’s [...]
Pioneering publication locates origin of Autophagosomal Membranes
November 12, 2013
Belfast -- The location of the site where autophagosomal membranes are created within the cell has been the subject of two competing models for many years. Now, a group of researchers from Osaka University led by Prof. Maho Hamasaki has located the origin of autophagosomes within the cell and shown that neither model is correct. [...]
NanoString Launches the nCounter Dx Analysis System for U.S. Market
November 12, 2013
SEATTLE -- NanoString Technologies, Inc., (NASDAQ: NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced the availability of the nCounter® Dx Analysis System for high-complexity, CLIA-certified laboratories. The nCounter Dx Analysis System is the only platform 510(k) cleared by the U.S. Food and Drug Administration to run the [...]
Gyros Immunoassay Platform Selected by BioAgilytix Labs to Support Bioanalysis Services
November 11, 2013
Uppsala, Sweden: Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced today that BioAgilytix Labs, a contract research organization (CRO) specializing in immunoassays and cell-based assays, based in Durham, North Carolina, has invested in two Gyrolab™ xP workstations to support its bioanalysis services. Dr. Afshin Safavi, Founder and Chief [...]
ZEISS Introduces New Technology for 3D Superresolution Microscopy
November 11, 2013
Jena/Germany, San Diego/USA -- Expanding its 3D microcopy portfolio, ZEISS is introducing superresolution photoactivated localization microscopy (PALM) in 3D at the Society for Neuroscience Annual Meeting in San Diego, California. With a new module, ELYRA P.1 now enables superresolution photoactivated localization microscopy (PALM) in 3D for endogenously-expressed photo-switchable fluorescent proteins. Users can capture highly resolved [...]
Illumina Names Francis deSouza as President
November 11, 2013
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced it has appointed Francis deSouza to the role of President. Mr. deSouza will report to Chief Executive Officer Jay Flatley and will lead Illumina's business units and the core functions responsible for envisioning, developing and producing the company’s products. He will also become part of Illumina's executive [...]
Australia is Newest Country to Deploy Battelle, Sellex Liquid Bottle Scanning Technology at Airports
November 11, 2013
COLUMBUS, Ohio -- No more pouring expensive liquor or pricy perfume down the drain in frustration while traveling through world airports and taking advantage of duty-free shops. Australian air travelers are joining other world airports using a new technology that will allow them to start bringing some liquids through security screenings and onto airplanes, knowing [...]
November 11, 2013
Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the availability of the CE-marked BD MAX MRSA XTassay in Europe for use on the BD MAX™ System. The assay uses eXTended detection technology to accurately identify a broad range of methicillin-resistant Staphylococcus aureus [...]
